Taxonomy and Pathogen Properties
The causative agent of Omsk hemorrhagic fever belongs to the family Flaviviridae and genus Flavivirus. It was first isolated in 1947 in the Omsk Region during an expedition led by M.P. Chumakov from human blood samples and ixodid ticks. Currently, two serotypes of this pathogen are recognized.
Biologically and antigenically, the virus is extremely close to the tick-borne encephalitis (TBE) virus and is often considered its modified strain. The main difference is that the Omsk pathogen does not possess prominent neurotropic properties. In laboratory settings, the microorganism can replicate in various cell cultures. However, a specific cytopathic effect (CPE) leading to complete destruction of the monolayer is observed exclusively when cultured on pig embryo kidney cells.
Epidemiological Features
Natural foci of the infection are historically localized in Western Siberia. Birds and small rodents serve as the natural reservoir, while pasture and burrow-dwelling marsh ticks act as the primary hosts and vectors.
A crucial link in pathogen circulation is the muskrat (Ondatra zibethicus). This animal is highly susceptible to the infection and actively contaminates water bodies. Pathogen introduction into water is also carried out by water voles, other mammals, and infected ticks parasitizing them.
The disease is characterized by a unique bimodal seasonality:
- Spring-autumn period ("spring-autumn fever") is driven by peak tick activity in nature.
- Autumn-winter period ("muskrat disease") is directly linked to the active muskrat trapping and hunting season.
Human transmission occurs via three routes:
- Transmissible: through the bite of an infected tick.
- Contact: through direct contact with infected animals (especially during skinning of muskrats).
- Alimentary (waterborne): by consuming or coming into contact with contaminated water.
Pathogenesis and Clinical Presentation
Following entry into the body and completion of the incubation period, which lasts from 2 to 10 days, systemic viral dissemination begins. The key pathogenic mechanism is damage to the vascular endothelium, leading to universal capillary toxicosis. Concurrently, the central nervous system and adrenal tissues are involved in the pathological process.
The disease presents in two forms:
- Typical (with hemorrhagic manifestations).
- Atypical (without hemorrhages).
Typical disease onset is acute, accompanied by prominent fever, severe intoxication symptoms, and a characteristic hemorrhagic syndrome. Although the virus initially lacks strong neurotropic properties, clinical signs of meningoencephalitis may be observed, indicating involvement of neural tissue.
The prognosis is generally favorable, with the case-fatality rate consistently remaining below 1%. Recovered individuals develop long-lasting and robust post-infection immunity.
Diagnostics and Prevention
Laboratory diagnostics rely on a combination of virological and serological methods. Patient blood is used to isolate the virus. The material is inoculated intracerebrally into white mice or cultured in pig embryo cells, followed by pathogen identification using serological assays. Serological testing is based on detecting specific antibodies in paired sera using tests such as the indirect hemagglutination inhibition test (HI), complement fixation test (CFT), or ELISA.
Emergency prophylaxis and targeted therapy involve administration of immunoglobulin (homologous preparations provide a more potent protective effect than heterologous ones).
In 1948–1949, an inactivated formalinized vaccine derived from the brains of infected white mice was developed. In modern medical practice, mass vaccine prophylaxis has been discontinued due to declining incidence and the relatively benign course of the infection. Active immunization is prescribed strictly according to epidemiological indications. Furthermore, modern tick-borne encephalitis (TBE) vaccines provide reliable cross-protection against Omsk hemorrhagic fever.